Cherepanov case

IIHF Chief Medical Officer Aubry comments on latest findings

OTTAWA - The IIHF has issued a statement in light of recent media reports on the October 13, 2008 death of Russia’s Alexei Cherepanov.

A report by the Russian news and information agency, Novosti, indicates that according to the Investigation Committee of the General Prosecutors Office, paramedics did not give the appropriate treatment to Cherepanov when the 19-year-old right wing for Avangard Omsk collapsed on the bench during a KHL game versus Vityaz Chekhov and later died.

In addition, the Novosti report mentions that investigators found Cherepanov suffered from chronic myocarditis, a condition in which insufficient blood reaches the heart.

The investigators stated: “The death was directly caused by a serious cardiovascular condition. No traces of alcohol or drugs were found in his blood and urine, however, tests for chemicals showed that Alexei Cherepanov had been using stimulants for several months.”

IIHF Chief Medical Officer Mark Aubry said: “The sport of ice hockey requires a lot of skill, and doping does not really help athletes improve their performance. The IIHF conducts frequent out-of-competition and in-competition doping control tests prior to and during IIHF events. We have had very few positive tests over the last few years. Between the 2003-04 and 2007-08 seasons, 1,298 in-competition tests were conducted, with a total of 10 positive results. Between 2004 and 2007, the IIHF, in conjunction with the World Anti-Doping Agency (WADA) and the national anti-doping agencies, performed 14,506 out-of-competition tests, with a total of 56 positive results. Having said that, there will still be athletes who will try to cheat and think that taking a banned substance may improve their performance. This case may also be an example of the detrimental effects of doping in sport.”

FOOTNOTE: The IIHF conducts frequent out-of-competition and in-competition doping control tests prior to and during IIHF events, such as the Olympics, the IIHF World Championships (all categories) and IIHF club competitions such as the Champions Hockey League. The national anti-doping agencies are responsible for testing within domestic leagues.

ADDENDUM: The KHL issued the following statement on Tuesday: "For at least a year prior to the incident Alexei Cherepanov suffered from chronic miochardia. In the blood of the player was found kordiamin, a drug used to stimulate and treat the heart and respiratory organs. It was found that kordiamin was put into the player three hours before the Vityaz-Avangard match of 13 October 2008. This preparation is on a list of substances prohibited by the World Anti-Doping Agency (WADA)."



The Tkachuk Way

Pousse to coach U20

Finnish threat

Return to the motherland

Tardif re-elected in France

Copyright IIHF. All rights reserved.
By accessing pages, you agree to abide by IIHF
Terms and Conditions | Privacy Policy